TORONTO, Oct. 3, 2023
/CNW/ - Neighbourly Pharmacy Inc. ("Neighbourly" or the
"Company") (TSX: NBLY), Canada's largest and fastest growing network
of independent pharmacies, announced today that, based on the
unanimous recommendation of a committee of independent directors
(the "Transaction Committee") of its board of
directors (the "Board"), it has entered into a letter of
intent with an affiliate of Persistence Capital Partners
(collectively, and together with their affiliated funds,
"PCP"), in respect of a transaction (the "Proposed
Transaction") whereby a newly-formed entity controlled by PCP
(the "Purchaser") would acquire all of the common shares
(the "Common Shares") in the capital of the Company, other
than those Common Shares already owned by PCP or its affiliates, at
a purchase price of $20.50 per Share
(the "Offer Price"), payable in cash. The Company has
granted the Purchaser exclusivity through November 13, 2023 to complete negotiations of
definitive agreements between the Company and the Purchaser.

The Offer Price represents approximately a 69% premium to the
closing price of $12.12 on the
Toronto Stock Exchange (the "TSX") on October 2, 2023, and approximately a 47% premium
to the 20-day volume weighted average price per share on the TSX of
$13.96, respectively, as of the end
of trading on October 2, 2023. The
Offer Price also represents a premium of approximately 21% to the
Company's May 2021 IPO price of
$17.00 per Common Share.
The Board, having received the unanimous recommendation of the
Transaction Committee, determined (with Stuart M. Elman, Chair of the Board and Managing
Partner of PCP, recusing himself from the meeting) that pursuing
the Proposed Transaction is in the best interests of the Company
and subject to negotiating a definitive agreement, receiving an
updated Fairness Opinion (as defined below) from TD (as defined
below) at the time the definitive agreement is entered into and
such other conditions described below being satisfied, the Board
intends to recommend that the Company's shareholders vote in favour
of the Proposed Transaction at a special meeting of shareholders to
be held to approve the Proposed Transaction.
"PCP believes that taking Neighbourly private is the best
way to unlock its full potential and create long-term value for all
stakeholders," said Stuart M. Elman,
Managing Partner of PCP. "As a private company,
Neighbourly will have more flexibility and resources to pursue
its strategic vision to advance the role that independent
pharmacies can play in Canada. We
are confident that this proposed transaction will benefit
Neighbourly's customers, patients, employees, and partners, as well
as provide a fair and attractive return to its public
shareholders."
In connection with its review of the Proposed Transaction, the
Transaction Committee retained TD Securities Inc. ("TD") to
provide financial advice and prepare a formal valuation of the
Common Shares (the "Formal Valuation") as required under
Multilateral Instrument 61-101 – Protection of Minority Security
Holders in Special Transactions ("MI 61-101"). TD delivered
an oral opinion to the Transaction Committee that, as of
October 2, 2023, and based on TD's
analysis and subject to the assumptions, limitations and
qualifications to be set forth in the Formal Valuation, the fair
market value of the Common Shares of the Company is in the range of
$20.50 to $25.50 per Common Share. TD has also
delivered an oral opinion (the "Fairness Opinion") to the
Transaction Committee that, as of October 2,
2023, and subject to the assumptions, limitations and
qualifications to be set forth in TD's written fairness opinion,
the consideration to be received by the holders of Common Shares
(other than the Purchaser or its affiliates) pursuant to the
Proposed Transaction is fair, from a financial point of view, to
the holders of Common Shares (other than the Purchaser or its
affiliates).
PCP, which owns as of the date hereof, directly or indirectly,
an aggregate of approximately 22.4 million Common Shares of the
Company, representing approximately 50.2% of the Company's issued
and outstanding Common Shares, expressed to the Board and the
Transaction Committee that it does not have any interest in selling
the Common Shares that it owns to any third party and that it would
not support any alternative transaction involving the Company and a
third party. The Company has agreed to negotiate definitive
agreements exclusively with PCP in connection with the Proposed
Transaction.
Transaction Details
Pursuant to the terms of the Proposed Transaction, the Purchaser
will acquire all of the Common Shares, other than those Common
Shares owned by PCP or its affiliates, for a purchase price of
$20.50 per Common Share, payable in
cash. The Proposed Transaction would be financed via equity and
debt financing, both of which are in advanced stages of
negotiations.
The entering into of a definitive agreement concerning the
Proposed Transaction will be subject to, among other things, as at
the time the definitive agreement is entered into, (i) PCP having
secured fully committed debt and equity financing; (ii) the
negotiation and execution of a definitive agreement for the
Proposed Transaction on terms satisfactory to PCP and Neighbourly;
(iii) receipt from TD of an updated Formal Valuation; and (iv)
receipt from TD of an updated Fairness Opinion, containing a
fairness conclusion consistent with the Fairness Opinion. The
consummation of the Proposed Transaction will be subject to various
conditions customary for transactions of this nature, including,
among others, (i) receipt by the Company and PCP of any
required regulatory, court and/or stock exchange approvals; and
(ii) the approval of the Proposed Transaction at a special meeting
of the shareholders of the Company entitled to vote on the Proposed
Transaction (including a "majority of the minority" vote of the
shareholders excluding for this purpose the votes of Shares held or
controlled by PCP and any other persons described in items (a)
through (d) of Section 8.1(2) of MI 61-101).
Neighbourly expects to hold a special meeting (the
"Special Meeting") of the Company's shareholders to approve
the Proposed Transaction following execution of definitive
agreements with respect to the Proposed Transaction. The Proposed
Transaction is expected to close in the last calendar quarter of
2023 or early in the first calendar quarter of 2024, subject to the
above listed conditions and other customary closing conditions. The
terms and conditions of the Proposed Transaction will be disclosed
in greater detail in a management information circular for the
Special Meeting that is expected to be mailed to the Company's
shareholders following the execution of the definitive agreement
for the Proposed Transaction. Copies of the definitive agreements
and of the management information circular for the Special Meeting
will be filed with Canadian securities regulators and will be
available on the SEDAR+ profile of Neighbourly at
www.sedarplus.com. Neighbourly's shareholders are urged to read
those and other relevant materials when they become available.
While the Board, after having received the unanimous
recommendation of the Transaction Committee, has determined to
pursue the Proposed Transaction, neither the Transaction Committee
nor the Board has approved the Proposed Transaction. There can be
no assurance that Neighbourly and PCP will enter into a definitive
agreement for the Proposed Transaction or that the Proposed
Transaction will occur as proposed or at all. Neither the Company
nor the Transaction Committee expect to make
further public comment regarding the matters contemplated herein
until a definitive agreement for the Proposed Transaction is
reached or the Proposed Transaction is abandoned.
PCP Early Warning
Disclosure
PCP currently beneficially owns or has control or direction
over, directly or indirectly, 22,420,922 Common Shares,
representing approximately 50.2% of the currently issued and
outstanding Common Shares.
PCP is expected to take actions in furtherance of the Proposed
Transaction. Accordingly, the Proposed Transaction could result in
one or more of the actions set forth in clauses (a) through (k) of
item 5 of PCP's updated early warning report to be filed on SEDAR+,
including a plan of arrangement or other corporate transaction
involving the Company, the delisting of the Common Shares from the
Toronto Stock Exchange and the Company ceasing to be a reporting
issuer in Canada. Other than as
described above, PCP does not have any future intentions of the
type referred to in clauses (a) through (k) of Item 5 of PCP's
updated early warning report to be filed on SEDAR+, although it
reserves the right to do so in the future.
PCP has its principal office located in Toronto at 60 Bloor Street West, Suite 404,
Toronto, ON M4W 3B8. The Company's
head office is located in Toronto
at 190 Attwell Drive, Unit 400, Toronto,
ON M9W 6H8. For further information and/or a copy of the
related early warning report to be filed on SEDAR+ under the
Company's profile at www.sedarplus.ca, please contact the general
counsel and secretary of PCP by email at:
zzelman@persistencecapital.com.
Forward Looking
Information
This news release contains "forward-looking information" and
"forward-looking statements" (collectively, "forward-looking
information") within the meaning of applicable securities laws.
This information includes, but is not limited to, statements
concerning our objectives, our strategies to achieve those
objectives, as well as statements made with respect to management's
beliefs, plans, estimates, projections and intentions, and similar
statements concerning anticipated future events, results,
circumstances, performance or expectations that are not historical
facts. In some cases, forward-looking information can be identified
by the use of forward-looking terminology such as "expects",
"estimates", "outlook", "forecasts", "projection", "prospects",
"intends", "anticipates", "believes", or variations of such words
and phrases or statements that certain actions, events or results
"may", "could", "would", "might", "will", "will be taken", "occur"
or "be achieved". In addition, any statements that refer to
expectations, intentions, projections or other characterizations of
future events or circumstances contain forward-looking information.
Statements containing forward-looking information are not
historical facts but instead represent management's expectations,
estimates and projections regarding future events or circumstances.
Forward-looking information in this news release, which includes,
among other things, statements relating to the Proposed Transaction
and timing thereof, is necessarily based on a number of opinions,
estimates and assumptions that the Company considered appropriate
and reasonable as of the date such statements are made in light of
its experience, current conditions and expected future
developments.
Risks and uncertainties related to the Proposed Transaction
include, but are not limited to: failure of Neighbourly and PCP to
enter into a definitive agreement for the Proposed Transaction on
terms satisfactory to Neighbourly, or at all; failure of PCP to
secure equity or debt financing on acceptable terms, or at all;
failure to complete satisfactory due diligence; failure of
Neighbourly and PCP to obtain the required shareholders and
regulatory approvals for, or satisfy other conditions to effect,
the Proposed Transaction; failure by TD to deliver an updated
Formal Valuation at the time the definitive agreement is entered
into; failure by TD to deliver an updated Fairness Opinion at the
time the definitive agreement is entered into; the risk that the
Proposed Transaction may involve unexpected costs, liabilities or
delays; the risk that, prior to or as a result of the completion of
the Proposed Transaction, the business of Neighbourly may
experience significant disruptions, including loss of clients or
employees due to transaction related uncertainty, industry
conditions or other factors; risks relating to employee retention;
the risk of regulatory changes that may materially impact the
business or the operations of Neighbourly; the risk that legal
proceedings may be instituted against Neighbourly; and risks
related to the diversion of management's attention from
Neighbourly's ongoing business operations.
Although we have attempted to identify important risk factors
that could cause actual results to differ materially from those
contained in forward-looking information, there may be other risk
factors not presently known to us or that we presently believe are
not material that could also cause actual results or future events
to differ materially from those expressed in such forward-looking
information. There can be no assurance that such information will
prove to be accurate, as actual results and future events could
differ materially from those anticipated in such information. No
forward-looking statement is a guarantee of future results.
Accordingly, you should not place undue reliance on forward-looking
information, which speaks only as of the date made. The
forward-looking information contained in this news release
represents the Company's expectations as of the date of this news
release (or as the date they are otherwise stated to be made) and
are subject to change after such date. However, the Company
disclaims any intention or obligation or undertaking to update or
revise any forward-looking information whether as a result of new
information, future events or otherwise, except as required under
applicable securities laws in Canada. All of the forward-looking information
contained in this news release is expressly qualified by the
foregoing cautionary statements.
About Neighbourly Pharmacy
Inc.
Neighbourly is Canada's largest
and fastest growing network of community
pharmacies. United by their patient first focus and their
role as essential and trusted healthcare hubs within their
communities, Neighbourly's pharmacies strive to provide
accessible healthcare with a personal touch. Since 2015,
Neighbourly has expanded its diversified national footprint to
include 291 locations, reinforcing the Company's reputation as the
industry's acquirer of choice.
Advisors
TD Securities is acting as financial advisor and independent
valuator to the Transaction Committee, and McCarthy Tétrault LLP is
acting as independent legal advisor to the Transaction
Committee.
Scotiabank and RBC Capital Markets are acting as financial
advisors to PCP, and Stikeman Elliott LLP is acting as legal
advisor to PCP on the Proposed Transaction. Devon Park
Advisors1 is providing strategic advisory and capital
raising services to PCP.
1 INTE
Securities LLC dba Devon Park Advisors is a member of FINRA
(www.finra.org) / SIPC (www.sipc.org) . To view INTE Securities
LLC, please go to www.finra.org/brokercheck
|
SOURCE Neighbourly Pharmacy Inc.